Cassini isn't just another medical device company; it's a surgical precision play targeting the $7B+ global cataract surgery market with a hyper-specialized diagnostic suite. With only 31 employees and $3.5M in revenue, this is a classic 'niche dominator' or a company that's severely under-monetizing a breakthrough technology.

"In a world obsessed with scaling, Cassini proves that surgical precision requires a small, focused team, not a bloated engineering department."

The leadership team reveals a mix of commercial and quality assurance focus. With Ernst Serfontein serving as Chief Commercial & Product Officer and Vita Boxhoorn handling Quality Assurance & Regulatory Affairs, Cassini is structured to navigate the strict FDA/CE compliance landscape. However, the lack of a clear CTO or VP of Engineering in the public data raises questions about their R&D velocity in a rapidly digitizing medical field.

• Hyper-Niche Focus: They ignore the broader ophthalmic market to own the cataract suite specifically.
• Lean Operations: $112k revenue per employee is respectable for a hardware/software hybrid.
• Offline Sales Model: The disconnect between revenue and web traffic indicates a heavy reliance on direct sales and medical conferences.